에 대한 최신 뉴스 Amer Sports (NYSE:AS) 주식

Amer Sports

Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $4.4 billion in 2023. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2023, the firm generates 40% of its revenue from the Americas, 33% from Europe, the Middle East, and Africa, 19% from China, and 7% from Asia-Pacific, excluding China.

New,York,Ny - usa-january,22,,2011,A,Gamestop,Video,Game,Store

Equities

Large Cap

News

Movers

CRWV

IONQ

NPSCY

NVDA

RYAAY

지난주 가장 좋은 성과를 보인 대형주는 다음과 같다. 게임스탑, 아이온큐, 코어위브 등 지난주 급등한 대형주 11종목 (5월 19일~23일)

게임스탑, 아이온큐, 코어위브 등 지난주 급등한 대형주 11종목 (5월 19일~23일)

chart

Analyst Color

Sector ETFs

Broad U.S. Equity ETFs

Hedge Funds

Econ #s

Analyst Ratings

ETFs

FSLR

Market Vectors ETF Trust Market Vectors Gold Miners

LCID

MEDP

MRNA

First Trust NASDAQ-100 Technology Index Fund

QTEC

S&amp;P 500 지수가 4월 이후 23% 급반등한 이후, 헤지펀드들은 투자자들이 관세 완화 랠리의 지속 가능성을 의심하는 가운데 주식에 대한 약세 베팅을 기록적인 수준으로 늘리고 있다. 

헤지펀드들, 주식에 대한 매도 포지션을 기록적으로 늘려

Fear and Greed

Earnings

Pre-Market Outlook

Markets

Trading Ideas

TSLA

CNN 머니 공포·탐욕 지수는 전반적인 시장 심리가 약간 하락했음을 보여 주었지만, 지수는 화요일(20일)에 &#34;탐욕&#34; 구역에 머물렀다.미국 증시는 화요일에 하락 마감했으며, 다우존스 지수는 거래 세션 중에 100포인트 이상 하락했다. S&amp;P 500 지수도 6거래일 연속 상승세를 끊었다.

S&amp;P 500, 6거래일 상승 후 숨고르기: 투자 심리 소폭 하락, 공포 지수는 여전히 &#39;탐욕&#39; 영역

Amer Sports Inc

ASA Gold And Precious Metals Ltd

AT & S AUSTRIA TECH & SYS by AT&S Austria Technologie & SystemTechnik AG Leoben

AT&S Austria Technologie & Systemtechnik AG

AUSTRALIAN AGRICULTURAL by Australian Agricultural Co Ltd.

Australian Agricultural Co Ltd

Sendas Distribuidora SA ADR (Sponsored)

SENDAS DISTRIBUDRA S/ADR by Sendas Distribuidora S.A.

Sendas Distribuidora SA

American Salars Lithium Inc

ASSURANCEAMERICA by AssuranceAmerica Corp.

Asana Inc

Waitr Holdings Inc

Aurora Spine Corp

WAITR HOLDINGS INC by Waitr Holdings Inc.

ASIA STANDARD INTL GP ORD by Asia Standard International Group Ltd.

Asia Standard International Group Ltd

ASI AVIATION INC by Asi Aviation Inc.

Assa Abloy AB

Associated Banc-Corp

Associated Banc-Corp 6.625% Fixed-Rate Reset Subordinated Notes due 2033

ASSOCIATED BRIT FOOD ORD by Associated British Foods plc

Associated British Foods PLC

ASSOCIATED BRI/F UNSP/ADR by Associated British Foods plc

ASAHI GROUP HLDGS U/ADR by Asahi Group Holdings Ltd.

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Holdings Inc

Aspire Biopharma Holdings, Inc. - Warrant

ASAHI GROUP HOLDINGS ORD by Asahi Group Holdings Ltd.

Asahi Group Holdings Ltd

Associated Banc-Corp Depositary Shares, each representing a 1/40th interest in a share of 5.875% Non-Cumulative Perpetual Preferred Stock, Series E

Associated Banc-Corp Depositary Shares, each representing a 1/40th interest in a share of Associated Banc-Corp 5.625% Non-Cumulative Perpetual Preferred Stock, Series F

Ardmore Shipping Corporation Common Stock

Ardmore Shipping Corp

A SPAC I ACQUISITION CORP USD CL A ORD SHS

A SPAC I ACQUISITION CORP USD RTS

A SPAC I ACQUISITION CORP USD UNITS CONSISTING ONE CL A ORD SH OF NO PAR VALUE & ONE

A SPAC I ACQUISITION CORP WT EXP

A SPAC II ACQUISITION CORP CL A

A SPAC II ACQ CORP by A SPAC II Acquisition Corp.

A SPAC II Acquisition Corp

ASCENDIA BRANDS INC by Ascendia Brands, Inc.

A SPAC II ACQUISITION CORP RT

A SPAC II ACQUISITION CORP UNIT 1 CL A& 1/2 WT EXP & 1 RT

A SPAC II ACQUISITION CORP WT EXP

ARISTOCRAT GRP CORP by Aristocrat Group Corp

Aristocrat Group Corp

ASICS Corp

ACOTEC SCIENTIFIC HLD ORD by ACOTEC SCIENTIFIC HLDGS LTD

Acotec Scientific Holdings Ltd

AMSC ASA

Auscrete Corp

ASCLETIS PHARMA INC by Ascletis Pharma Inc.

Ascletis Pharma Inc

Absecon Bancorp

ASCOPIAVE SPA TREVISO ORD by Ascopiave SPA Treviso

Ascopiave SpA

AMER CRYSTAL SUGAR PFD by American Crystal Sugar Co.

American Crystal Sugar Co

ARIZONA SONORAN COPPER CO by Arizona Sonoran Copper Company Inc.

Arizona Sonoran Copper Co Inc

A SPAC II Acquisition Corp Warrants (15/10/2026)

Astro Aerospace Ltd

Ascendant Resources Inc

ARCTIC STAR EXPL CORP by Arctic Star Exploration Corp.

Arctic Star Exploration Corp

Global X FTSE Southeast Asia ETF

APT SATELLITE HOLDINGS by APT Satellite Holdings Ltd.

APT Satellite Holdings Ltd

AISIN SEIKI CO LTD ORD by Aisin Corporation

Aisin Corp

FlexShares Real Assets Allocation Index Fund

ASIAFIN HLDGS CORP by ASIAFIN HOLDINGS CORP.

Asiafin Holdings Corp

ASFG INC by ASFG, Inc.

APPSOFT TECHNOLOGIES INC by AppSoft Technologies, Inc.

AppSoft Technologies Inc

AMERICAN SCIENTFC RES by American Scientific Resources, Inc.

American Scientific Resources Inc

Associates First Capital Corp

Liberty All Star Growth Fund Inc

abrdn Global Infrastructure Income Fund Common Shares of Beneficial Interest

abrdn Global Infrastructure Income Fund

AGC Inc

ASGN Inc

Asante Gold Corp

ASTRALIS A/S by Astralis A/S

Altri SGPS SA

Altus Group Ltd

ASIA GLOBAL CROSSING A by Asia Global Crossing Ltd.

Asia Global Crossing Ltd

Ashland Inc

Ashtrom Group Ltd

ASBERRY 22 HLDGS INC by ASBERRY 22 HLDGS INC.

Asberry 22 Holdings Inc

ASHLEY SVCS GROUP LTD by ASHLEY SVCS GROUP LTD.

Ashley Services Group Ltd

Xtrackers Harvest CSI 300 China A-Shares ETF

Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF

Ashtead Group PLC

ASHTED GRP PLC UNSP/ADR by Ashtead Group PLC

DBX ETF Trust Xtrackers MSCI China A Inclusion Equity ETF

PROGRESSIVE PLANET NEW by Progressive Planet Solutions Inc.

Progressive Planet Solutions Inc

Matthews International Funds Matthews Pacific Tiger Active ETF

Ategrity Specialty Insurance Company Holdings Common Stock

Ategrity Specialty Insurance Co Holdings

ACCREDITED SOLUTIONS INC by Accredited Solutions Inc.

Accredited Solutions Inc

AdvanSix Inc

Permission Coin

ALASKA PACIFIC ENERGY by Alaska Pacific Energy Corp.

Alaska Pacific Energy Corp

ASTIKA HOLDINGS INC by Astika Holdings, Inc.

Astika Holdings Inc

ASKUL Corp

ASKA PHARM HLDGS CO LTD by ASKA PHARMACEUTICAL HLDGS CO LTD

ASKA Pharmaceutical Holdings Co Ltd

AerSale Corp

ASL MARINE HLDGS LTD by ASL Marine Holdings Ltd.

ASL Marine Holdings Ltd

ABRDN EUROPEAN LOGISTICS by ABRDN EUROPEAN LOGISTICS INCOME PLC

<a href="https://www.youtube.com/watch?v=xknz4c0oh74">https://www.youtube.com/watch?v=xknz4c0oh74</a>

Politics

General

iShares MSCI Israel Capped Investable Market Index Fund

Russia's UN Ambassador Says Israel's Actions Risk Pulling In Third Countries Into Conflict; Demands Israel Immediately Cease Attacks And Raids On Iran;  Says Targeting Of Iran's Peaceful Civilian Nuclear Facilities 'liable To Plunge Us Into A Hither To Unseen Nuclear Catastrophe'; Says Internationalization Of Israel Iran Conflict Must Be Avoided

KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) will release earnings results for the second quarter, after the <a href="https://www.benzinga.com/quote/KBH/earnings">closing bell on Monday, June 23</a>.
Analysts expect the Los Angeles, California-based company to report quarterly earnings at $1.47 per share, down from $2.15 per share in the year-ago period. KB Home projects to report quarterly revenue at $1.51 billion, compared to $1.71 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 24, KB Home reported worse-than-expected first-quarter EPS and sales results.
KB Home shares rose 0.02% to close at $50.62 on Wednesday.
Benzinga readers can access the latest analyst ratings on the &lt;a href=&#8221;https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie&#8221;&gt;&lt;em&gt; <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> &lt;/em&gt;&lt;/a&gt; page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate &lt;a href=&#8221;https://www.benzinga.com/quote/HCA/analyst-ratings&#8221;&gt;&lt;em&gt; <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">analysts have rated the company</a> &lt;/em&gt;&lt;/a&gt; in the recent period.
<ul class="wp-block-list">
<li>Wells Fargo analyst Sam Reid maintained an Underweight rating and cut the price target from $55 to $53 on June 3, 2025. This analyst has an accuracy rate of 63%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintained a Market Perform rating and cut the price target from $76 to $65 on March 26, 2025. This analyst has an accuracy rate of 67%.</li>
<li>RBC Capital analyst Mike Dahl maintained a Sector Perform rating and lowered the price target from $67 to $63 on March 25, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Wedbush analyst Jay McCanless reiterated a Neutral rating with a price target of $75 on March 25, 2025. This analyst has an accuracy rate of 85%.</li>
<li>Barclays analyst Matthew Bouley maintained an Equal-Weight rating and cut the price target from $60 to $56 on March 25, 2025. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying RH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/kbh/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20032427/image-302-1024x594.png" alt="" class="wp-image-955584" style="width:666px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20032427/image-302-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20032427/image-302-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20032427/image-302-768x445.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20032427/image-302.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45993572/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Industrials Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Price Target

KB Home Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Pivotal Research analyst Jeffrey Wlodarczak maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Buy and raises the price target from $1350 to $1600.

NFLX

Pivotal Research Maintains Buy on Netflix, Raises Price Target to $1600

Shares of KWESST Micro Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWE#NASDAQ">KWE</a>) climbed 11.5% higher to $12.50 Friday morning before pulling back, continuing volatility after surging <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46002054/kwesst-micro-systems-kwe-stock-soars-over-100-after-announcing-major-defense-contract">more than 100%</a> on Wednesday.
What To Know: The rally follows the company's announcement that it secured its first order for its next-generation Battlefield Laser Detection System from a defense systems integrator supporting a major North American armored vehicle program.
The market this week appears to be view the contract as validation of KWESST's technology. CEO Sean Homuth emphasized the BLDS as a cost-effective, flexible solution designed to protect both soldiers and vehicles from laser-guided threats. "Lasers are now a silent, invisible threat&#8230; BLDS gives them back those seconds so they have a fighting chance," Homuth said.
The BLDS is engineered to detect and counter laser target designators and range finders, offering enhanced survivability on modern battlefields. KWESST noted that initial prototypes are ready for delivery, with full performance testing to follow. A fully-networked version is expected by fall 2025.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/06/46025785/marvell-technology-stock-levels-look-right-heres-what-to-watch">Marvell Technology: Stock Levels Look Right, Here&#8217;s What To Watch</a>
<h2 class="wp-block-heading">How To Buy KWE Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in KWESST Micro Systems&#8217; case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

KWESST Micro Systems (KWE) Stock Extends Rally On Defense Contract Win

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Seaport Global analyst Jeff Cantwell initiated coverage on Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) with a Buy rating and announced a price target of $235. Circle Internet Group shares closed at $199.59 on Wednesday. <a href="https://www.benzinga.com/quote/crcl/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Macquarie analyst Chad Beynon initiated coverage on Sportradar Group AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) with an Outperform rating and announced a price target of $32. Sportradar shares closed at $25.20 on Wednesday. <a href="https://www.benzinga.com/quote/srad/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Janney Montgomery Scott analyst Robert Farnam initiated coverage on Everest Group, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) with a Buy rating. Everest Group shares closed at $332.90 on Wednesday. <a href="https://www.benzinga.com/quote/eg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CICC initiated coverage on Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with an Outperform rating and announced a price target of $225. Snowflake shares closed at $212.08 on Wednesday. <a href="https://www.benzinga.com/quote/snow/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Joseph Tumillo initiated coverage on Kinsale Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) with a Buy rating and announced a price target of $543. Kinsale Cap shares closed at $460.87 on Wednesday. <a href="https://www.benzinga.com/quote/knsl/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SNOW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="569" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20105155/image-314-1024x569.png" alt="" class="wp-image-956290" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20105155/image-314-1024x569.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20105155/image-314-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20105155/image-314-768x427.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20105155/image-314.png 1153w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46024423/how-to-earn-500-a-month-from-commercial-metals-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q3 Earnings</a> </li>
</ul>
Photo via Shutterstock

Initiation

CRCL

KNSL

SNOW

SRAD

This Snowflake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Oppenheimer analyst Jason Helfstein maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Outperform and raises the price target from $215 to $250.

AMZN

Oppenheimer Maintains Outperform on Amazon.com, Raises Price Target to $250

WIIM

GPUS

GPUS stock has given up its prior gain. Hyperscale Data shares were trading higher after the company announced its Bitnile.com said it accepts $TRUMP meme coin to its social casino games.

Oppenheimer analyst Hartaj Singh maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Outperform and lowers the price target from $123 to $45.

SRPT

Oppenheimer Maintains Outperform on Sarepta Therapeutics, Lowers Price Target to $45

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) and Sanofi SA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent&nbsp;(dupilumab) for adult patients with bullous pemphigoid (BP), a rare, chronic <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">autoimmune skin disorder</a>.
BP primarily affects elderly patients and is characterized by intense itch, painful blisters and lesions, and skin reddening. It can be chronic and relapsing with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46019439/dupixent-dupilumab-approved-in-the-u-s-as-the-only-targeted-medicine-to-treat-patients-with-bullou" rel="noreferrer noopener">underlying type 2 inflammation</a>.
The blisters and rash can form over much of the body and cause the skin to bleed and break down, making patients more prone to infection.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45692578/regeneron-sanofi-stock-falls-after-uneven-smokers-lung-drug-data" rel="noreferrer noopener">Regeneron, Sanofi Stock Falls After Uneven Smoker&#8217;s Lung Drug Data</a>
The FDA approval is based on data from the pivotal ADEPT Phase 2/3 trial that evaluated the efficacy and safety of Dupixent compared to placebo in adults with moderate-to-severe BP.
Patients were randomized to receive Dupixent 300 mg (n=53) or placebo (n=53) added to standard-of-care oral corticosteroids (OCS).
During treatment, all patients underwent a protocol-defined OCS tapering regimen if control of disease activity was maintained.
The FDA-approved results at 36 weeks in the label for Dupixent compared to placebo are:
<ul class="wp-block-list">
<li>18.3% of patients experienced sustained disease remission compared to 6.1%, the primary endpoint.</li>
<li>38.3% of patients achieved clinically meaningful itch reduction compared to 10.5%.</li>
<li>The median cumulative OCS dose was 2.8 grams compared to 4.1 grams.</li>
</ul>
In this elderly population, the most common adverse events (≥2%) more frequently observed in patients on Dupixent compared to placebo were arthralgia, conjunctivitis, blurred vision, herpes viral infections, and keratitis.
Additionally, one acute generalized exanthematous pustulosis was reported in 1 patient treated with Dupixent and zero treated with placebo.
In April, the FDA approved Dupixent&nbsp;for adults and adolescents aged 12 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite histamine-1 (H1) <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44931246/regeneron-partners-with-japan-based-fujifilm-to-bolster-us-manufacturing-capacity-via-3-billion-d" rel="noreferrer noopener">antihistamine treatment</a>.
Price Action: REGN stock closed at $513.58 on Wednesday. SNY stock is up 1.45% at $48.31&nbsp;during the premarket session at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/45724030/kymera-therapeutics-says-atopic-dermatitis-potential-matches-sanofi-regenerons-blockbuster-dupixent-in-early-biomarker-response" target="_blank" rel="noreferrer noopener">Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron&#8217;s Blockbuster Dupixent In Early Biomarker Response</a></li>
</ul>
Image: Shutterstock

Biotech

Health Care

REGN

FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder

A recent call on &#8220;<a href="https://www.youtube.com/watch?v=0mpmCnW2Tmc">The Ramsey Show</a>&#8221; delivered a shocking back-to-back contrast. One caller had just explained how they were surviving on $850 a month. Moments later, a 22-year-old named Zack called in to say he was making between $30,000 and $90,000 a month by day <a href="https://www.benzinga.com/money/futures">trading futures</a>.
<h2 class="wp-block-heading">From Finance Major To Full-Time Trader</h2>
Zack explained that he studied finance at Lipscomb University in Nashville and started trading with just $3,000. &#8220;I decided to use my initial investment for evaluations with a few <a href="https://www.benzinga.com/money/best-prop-trading-firms">prop firms</a>,&#8221; he said. &#8220;You use their capital and get to keep 70 to 90 percent of the profits.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
He's been trading live accounts since February or March and says it only takes him three to four hours a day. &#8220;A bad day would be me breaking even or only losing about a thousand or two,&#8221; Zack said.
George Kamel, one of the co-hosts, asked the obvious question: &#8220;If you&#8217;re so good at this, why not use your own money?&#8221; Zack&#8217;s response came down to caution. &#8220;I was raised a Ramsey kid,&#8221; he said. Instead of using his own money, he <a href="https://www.benzinga.com/money/best-funded-trading-programs">trades with firm capital</a> to avoid personal risk. &#8220;I don&#8217;t have $150,000 I want to invest, and if someone else is going to take on the risk for me&#8230; the less risk and the more success, then that's kind of where I was going with it,&#8221; he added.
<h2 class="wp-block-heading">A Young Trader Thinking Ahead</h2>
Zack said he currently has about $50,000 in liquid savings, no debt, and lives on around $4,000 a month. He also said he&#8217;s putting aside 40 percent for taxes based on advice from his CPA godfather.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
Now he wants to <a href="https://www.benzinga.com/money/how-to-invest-in-real-estate">get into real estate</a> and &#8220;maybe do some fix-and-flips.&#8221; However, he wants to do it outside Middle Tennessee, as &#8220;it&#8217;s not cheap right now.&#8221;
Co-host Rachel Cruze jumped in with caution: &#8220;We always say if you&#8217;re going to go beyond your primary residence, you want to do it with cash.&#8221;
She advised Zack to focus on buying a primary residence first and avoid <a href="https://www.benzinga.com/money/how-to-start-flipping-houses-with-no-money">loans for flips</a>, citing how Dave Ramsey himself <a href="https://www.benzinga.com/startups/24/10/41496567/i-splatted-it-hurt-says-dave-ramsey-referring-to-the-sudden-call-on-his-1-2-million-loans-that-turne">went bankrupt</a> by borrowing heavily in real estate. &#8220;That's the wrong way to do it from Ramsey's standpoint,&#8221; she said.
While Zack said he might take out a loan to flip a property and pay it off after the sale, Cruze pushed back: &#8220;Cash is everything,&#8221; with Kamel warning, &#8220;I would not count on this gravy train of day trading for too long.&#8221;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

A Dave Ramsey Caller Claims To Make $30K–$90K A Month Day Trading. After A Story Of Someone Earning $850 Monthly, The Contrast Was Jarring

<a href="https://tsdr.uspto.gov/#caseNumber=99240420&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch">https://tsdr.uspto.gov/#caseNumber=99240420&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch</a>

Comments

Amer Sports

뉴스

에 대한 최신 뉴스 Amer Sports (NYSE:AS) 주식

일요일, 5월 25, 2025

수요일, 5월 21, 2025

금요일, 4월 04, 2025

일요일, 12월 15, 2024

일요일, 11월 24, 2024

일요일, 8월 25, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌